Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan
· Delayed Price · Currency is JPY 294.00
+4.00 (1.38%)
Mar 10, 2026, 10:00 AM JST
Taiko Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,573 | 14,975 | 16,614 | 15,082 | 17,193 | 35,911 | Upgrade
|
| Market Cap Growth | -12.55% | -9.87% | 10.16% | -12.28% | -52.12% | -48.57% | Upgrade
|
| Enterprise Value | 11,133 | 12,210 | 14,070 | 13,285 | 17,038 | 34,790 | Upgrade
|
| Last Close Price | 290.00 | 298.00 | 327.28 | 299.60 | 389.58 | 814.75 | Upgrade
|
| PE Ratio | 15.78 | 16.22 | 18.50 | - | - | - | Upgrade
|
| Forward PE | 22.41 | - | - | - | - | - | Upgrade
|
| PS Ratio | 2.28 | 2.34 | 2.64 | 2.46 | 3.41 | 3.18 | Upgrade
|
| PB Ratio | 1.71 | 1.76 | 2.09 | 2.24 | 2.14 | 2.80 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.77 | 2.09 | 2.24 | 2.20 | 2.87 | Upgrade
|
| P/FCF Ratio | 27.86 | 28.63 | 81.04 | - | - | - | Upgrade
|
| P/OCF Ratio | 17.90 | 18.40 | 45.90 | - | - | - | Upgrade
|
| PEG Ratio | - | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | Upgrade
|
| EV/Sales Ratio | 1.74 | 1.91 | 2.24 | 2.17 | 3.38 | 3.08 | Upgrade
|
| EV/EBITDA Ratio | 15.38 | 16.86 | 15.88 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 24.25 | 26.60 | 22.33 | - | - | - | Upgrade
|
| EV/FCF Ratio | 21.29 | 23.35 | 68.64 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.26 | 0.48 | 0.47 | 0.37 | Upgrade
|
| Debt / EBITDA Ratio | 1.13 | 1.13 | 2.29 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 1.56 | 1.56 | 9.89 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.31 | -0.33 | 0.04 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.75 | -4.75 | -2.83 | 7.38 | -0.13 | 0.33 | Upgrade
|
| Net Debt / FCF Ratio | -6.58 | -6.58 | -12.22 | 5.52 | -0.15 | 0.43 | Upgrade
|
| Asset Turnover | 0.51 | 0.51 | 0.48 | 0.43 | 0.27 | 0.42 | Upgrade
|
| Inventory Turnover | 1.77 | 1.77 | 1.72 | 2.13 | 1.54 | 1.78 | Upgrade
|
| Quick Ratio | 2.67 | 2.67 | 2.44 | 2.45 | 1.90 | 2.35 | Upgrade
|
| Current Ratio | 3.36 | 3.36 | 3.07 | 2.99 | 2.71 | 3.19 | Upgrade
|
| Return on Equity (ROE) | 11.20% | 11.20% | 12.22% | -48.86% | -46.96% | -53.92% | Upgrade
|
| Return on Assets (ROA) | 2.28% | 2.28% | 3.01% | -4.45% | -10.24% | -11.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.38% | 8.39% | 12.64% | -15.65% | -31.05% | -33.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 4.70% | 6.30% | -9.90% | -25.10% | -27.20% | Upgrade
|
| Earnings Yield | 6.33% | 6.16% | 5.41% | -23.94% | -28.47% | -26.72% | Upgrade
|
| FCF Yield | 3.59% | 3.49% | 1.23% | -2.68% | -11.97% | -8.55% | Upgrade
|
| Dividend Yield | 1.17% | 1.11% | - | - | - | - | Upgrade
|
| Payout Ratio | - | - | 0.11% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.11% | -0.11% | -5.96% | -8.62% | -0.21% | -0.35% | Upgrade
|
| Total Shareholder Return | 1.06% | 1.00% | -5.96% | -8.62% | -0.21% | -0.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.